...
首页> 外文期刊>Scientific reports. >Oxygen-18 isotope of breath CO2 linking to erythrocytes carbonic anhydrase activity: a biomarker for pre-diabetes and type 2 diabetes
【24h】

Oxygen-18 isotope of breath CO2 linking to erythrocytes carbonic anhydrase activity: a biomarker for pre-diabetes and type 2 diabetes

机译:氧气-18呼吸有效同位素 2 连接到红细胞碳酸酐酶活性:糖尿病前糖尿病和2型糖尿病的生物标志物

获取原文

摘要

Carbonic anhydrase (CA), a well-characterized metalloenzyme, is associated with oxygen-18 ( 18O)-isotopic fractionations of CO2. To investigate how CA activity links the 18O of breath CO2 to pre-diabetes (PD) and type 2 diabetes (T2D) during metabolism, we studied pre- and post-dose CA activities in erythrocytes with simultaneous monitoring of 18O/ 16O-isotope ratios of breath CO2 and thereafter elucidated potential metabolic pathways underlying CA alteration in the pathogenesis of T2D. Here we show that the post-dose CA activity in both T2D and PD was markedly enhanced, whereas the non-diabetic controls (NDC) exhibited a considerable reduction in post-dose CA activity when compared with their basal CA activities. However, T2D and PD exhibited isotopic enrichments of 18O in breath CO2, while a marked depletion of 18O in CO2 was manifested in NDC. Thus, the isotopic enrichments and depletions of 18O in breath CO2 were well correlated with the changes in CA activities for controls, PD and T2D. Our findings suggest the changes in CA activities in erythrocytes may contribute to the pathogenesis of T2D and the breath C 18O 16O regulated by the CA activity as a potential biomarker for non-invasive assessment of T2D, and thus may open a new method for treating T2D.
机译:碳酸酐酶(CA),一种表征良好的金属酶,与氧-18( 18-sup> o)相关的CO 2 的同位分子。为了研究Ca Active如何将呼吸有效期的 18 o链接到新陈代谢期间的糖尿病(pd)和2型糖尿病(t2d),我们研究预先和帖子 - 红细胞中的Ca活性,同时监测 18 O / 16 O-同位素比的呼吸co 2 ,然后阐明潜在的代谢途径T2D发病机制中的CA改变。在这里,我们表明,T2D和Pd的后剂量CA活性显着提高,而非糖尿病对照(NDC)与其基础CA活性相比,在剂量CA活动中表现出相当大的降低。然而,T2D和PD在呼吸CO 2 中表现出同位素富集的 18-sup> o,而CO 2中标记的 18-sup> o的显着耗尽在NDC中表现出。因此,呼吸CO 2 中 18-sup> o的同位素富集和耗尽与对照,Pd和t2d的Ca活性的变化很好。我们的研究结果表明红细胞中的Ca活性的变化可能导致T2D的发病机制和通过Ca活性调节的T2D和呼吸C 18℃ 16 O作为非潜在生物标志物-IVASIVE评估T2D,因此可以打开一种治疗T2D的新方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号